R. Owens

Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.

G. Tricot, P. Lin, Carla S. Wilson, 2004, American journal of clinical pathology.

Development of an unbiased, semi‐automated approach for classifying plasma cell immunophenotype following multicolor flow cytometry of bone marrow aspirates

S. Post, R. Owens, G. Post, 2018, Cytometry. Part B, Clinical cytometry.

Syndecan-1 (CD138) Immunoreactivity in Bone Marrow Biopsies of Multiple Myeloma: Shed Syndecan-1 Accumulates in Fibrotic Regions

M. Dhodapkar, R. Sanderson, Carla S. Wilson, 2001, Modern Pathology.

Secondary pericardial malignancies: a critical appraisal of the role of cytology, pericardial biopsy, and DNA ploidy analysis.

R. Bardales, M. Stanley, R. Owens, 1996, American journal of clinical pathology.

Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16.

B. Barlogie, R. Owens, R. Hoover, 1995, The Journal of clinical investigation.

Reticulocyte counting by flow cytometry. A comparison with manual methods.

R. Owens, A. Pappas, J. Flick, 1992, Annals of clinical and laboratory science.

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma

Caleb K. Stein, B. Barlogie, G. Morgan, 2015, Leukemia.

Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma.

B. Barlogie, J. Shaughnessy, R. Lorsbach, 2012, American journal of clinical pathology.